Search results
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 1 day agoModerna won regulatory approval for its RSV shot for people 60 and older by showing efficacy of more than 83% after an average of 3.7 months of...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 1 day agoAbrysvo, another RSV vaccine from Pfizer, also earned approval last May for those 60 or older....
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 4 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 4 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Moderna's RSV Vaccine Approved by FDA
Medscape· 2 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
US approves Moderna’s RSV vaccine for older adults | FOX 28 Spokane
FOX 28 Spokane· 4 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which...
Moderna's RSV vaccine for older adults approved
Axios· 4 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 4 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The FDA...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoNext week, the Center for Disease Control and Prevention's VRBPAC (Vaccines and Related Biological...
FDA approves Moderna's RSV vaccine, its second marketed product
USA TODAY via Yahoo News· 4 days agoThe company's shares fell last February after new data showed faster declines in the efficacy of its RSV vaccine compared to the GSK and Pfizer ...
